PKM and cancer: In addition, it has been proposed that HA344 inhibits the final and rate-limiting steps of glycolysis by covalently binding to PKM2 while blocking the effect of inosine monophosphate dehydrogenase activity, and the authors described the considerable potential of HA344 in overcoming cancer resistance (89).